FIELD: medicine, ophthalmology.
SUBSTANCE: the present innovation deals with applying a composition that contains antagonists of integrin αvβ3 and/or αvβ5 receptors for manufacturing the medicinal preparation indicated for treating angioproliferative ocular diseases. The compositions mentioned could be presented as nanoparticles. Application of the declared compositions provides the chance for intravitreous introduction.
EFFECT: higher efficiency of therapy.
46 cl, 1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF CHROMENONE AND CHROMANONE AS INTEGRIN INHIBITORS | 1999 |
|
RU2234505C2 |
| BICYCLIC AROMATIC AMINO ACIDS | 1998 |
|
RU2187506C2 |
| NEW CYCLOALKYL DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND ANTAGONISTS OF VITRONECTINE RECEPTOR | 1997 |
|
RU2180331C2 |
| SUBSTITUTED DERIVATIVES OF BENZOQUINOLISINE | 2005 |
|
RU2401267C2 |
| DERIVATIVES OF INDOLE-3-YL | 2001 |
|
RU2257380C2 |
| DERIVATIVES OF BETA-ALANINE | 2000 |
|
RU2234496C2 |
| SUBSTITUTED DERIVATIVES OF PURINE, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL PREPARATION | 1997 |
|
RU2228335C2 |
| CYLLOPEPTIDE DERIVATIVES | 1996 |
|
RU2174520C2 |
| NOVEL IMINO-DERIVATIVES AS INHIBITORS OF BONE RESORPTION AND ANTAGONISTS OF VITRONECTIN RECEPTOR | 1997 |
|
RU2197476C2 |
| TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS | 2011 |
|
RU2661410C2 |
